Recent News for AYTU - Aytu BioScience, Inc.

Date Title
Apr 5 New finance chief at Aytu BioPharma
Apr 5 Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial Officer
Apr 2 Aytu BioPharma Sells U.S. Rights For Natesto To Acerus Pharma; Street Sees 131.5% Upside
Apr 1 Aytu BioPharma sells U.S. rights to Natesto to Acerus
Apr 1 Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma
Mar 30 Ascendis downgraded at Oppenheimer, Aytu initiated at overweight at Cantor and more in today's analyst action
Mar 22 Aytu Bioscience closes merger with Neos Therapeutics
Mar 22 Aytu BioScience Announces Close of Merger with Neos Therapeutics
Mar 18 Why Did Aytu Biosciences Gap Up Today? Technical Levels To Watch
Mar 18 HEXO, CSIQ, LAZR and SIG among premarket gainers
Mar 18 Why Are Neos Therapeutics, Aytu BioScience Stocks Soaring Today?
Mar 14 Aytu BioScience: The Moonshot Continues To Orbit Awaiting The Next Giant Steps
Mar 12 Aytu Bioscience, Inc. (AYTU) Moves 9.2% Higher: Will This Strength Last?
Mar 9 The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Mar 8 Aytu stock jumps on UVA light catheter COVID-19 trial data
Mar 8 Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 Patients
Feb 24 Aytu BioScience to Present at Upcoming March Investor Conferences
Feb 14 A Quick Analysis On Aytu BioScience's (NASDAQ:AYTU) CEO Salary
Feb 12 The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Feb 12 Aytu BioScience, Inc. (AYTU) CEO Joshua Disbrow on Q2 2021 Results - Earnings Call Transcript
Feb 11 Aytu BioScience EPS misses by $0.28, beats on revenue
Feb 11 Aytu BioScience Announces Record Fiscal Q2 2021 Net Revenue of $15.1 Million, an Increase of 377% Year-Over-Year
Feb 11 The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Feb 11 Earnings Scheduled For February 11, 2021
Feb 10 Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021
Back to the Main AYTU Page...